Table 3

Patient characteristics (thrombolytic treatment)

Thrombus location	Estimated thrombus age	Thrombolytic agent	Dose administered	Duration of treatment	Short-term outcome
Unilateral femoral artery	1 day	t-PA	1.5 mg/kg/day	2 days	Complete patency
Unilateral femoral artery^3-150	?	t-PA	0.5 mg/day	3 days	Complete patency
External iliacal artery/abdominal aorta		3 days		t-PA^**		7.2 mg/kg/day	9 hours	Failure
External iliacal artery/abdominal aorta		3 days		t-PA^**		3.6 mg/kg/day	3 days	Failure
Unialteral femoral artery	3 days	UK	4000 U/hour	3 days	Complete patency
Unilateral brachial artery	?	t-PA^†	1.4 mg/kg/day	10 days	Complete patency
Bilateral external iliacal arteries	Connatal	t-PA	−12 mg/kg/day	30 days	Partial patency

t-PA: recombinant tissue type plasminogen activator; UK: urokinase.
↵3-150 Associated with central line; ^** bleeding from puncture sites; ^†cross-over from UK.